Validated reverse phase HPLC method for the determination of irinotecan in pharmaceutical dosage forms

E-Journal of Chemistry

Volumn 4, Issue 1, 2007, Pages 128-136

  Murali Balaram, V ^a   Venkateswara Rao, J ^a   Ramakrishna, S ^b   Sankar Ganesh, G ^b   Balamurali Krishna, T ^c  

^a SULTAN UL ULOOM COLLEGE OF PHARMACY   (India)

^b INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

^c BGSS Pharma   (India)

Author keywords

Irinotecan; PDA; RP HPLC

Indexed keywords

EID: 33847780392     PISSN: None     EISSN: 09734945     Source Type: Journal    
DOI: 10.1155/2007/597409     Document Type: Article

References (10)

1. th Edition, 580.
2. th edition,2001,5109, Merck Research lab.
3. Yang X, Hu Z, Chan SY, Goh BC, Duan W, Chan E, Zhou S,J Chromatogr B Analyt Technol Biomed Life Sci., 2005,821,221.
4. Poujol S, Pinguet F, Malosse F, Astre C, Ychou M, Culine S, Bressolle F. Clin Chem, 2003 ,49,1900.
5. de Jong FA, Mathijssen RH, de Bruijn P, Loos WJ, Verweij J, Sparreboom A.J Chromatogr B Analyt Technol Biomed Life Sci, 2003,795, 383.
6. Schoemaker NE, Rosing H, Jansen S, Schellens JH, Beijnen JH. Ther Drug Monit, 2003,25,120.
7. Rivory LP, Robert J.,J Chromatogr B Biomed Appl, 1994,661,133.
8. Barilero I, Gandia D, Armand JP, Mathieu-Boue A, Re M, Gouyette A, Chabot GG.J Chromatogr, 1992,575, 275.
9. Validation of Analytical Methods: Definitions and Terminology, ICH Harmonised Tripartite Guideline, ICH Topic Q2A, 1994.
10. Validation of Analytical Procedures,Methodology, Step 4, Consensus,ICH Harmonised Tripartite Guideline, Guideline, 1996.